No statistically significant differences in age, sex, body mass index (BMI), comorbidity, smoking history, tumor stage, abnormal CEA or CA19‐9 levels, organ of metastasis, previous surgery for primary cancer, or treated with radiotherapy were observed between the S‐1‐treated and non‐S‐1‐treated groups. The gene discussed is CEACAM5; the disease is cancer.